BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14761891)

  • 1. An LQT mutant minK alters KvLQT1 trafficking.
    Krumerman A; Gao X; Bian JS; Melman YF; Kagan A; McDonald TV
    Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1453-63. PubMed ID: 14761891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome.
    Bianchi L; Shen Z; Dennis AT; Priori SG; Napolitano C; Ronchetti E; Bryskin R; Schwartz PJ; Brown AM
    Hum Mol Genet; 1999 Aug; 8(8):1499-507. PubMed ID: 10400998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel.
    Wang W; Xia J; Kass RS
    J Biol Chem; 1998 Dec; 273(51):34069-74. PubMed ID: 9852064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits.
    Franqueza L; Lin M; Shen J; Splawski I; Keating MT; Sanguinetti MC
    J Biol Chem; 1999 Jul; 274(30):21063-70. PubMed ID: 10409658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of the arrhythmogenic G306R KvLQT1 K+ channel mutant probed by viral gene transfer in cardiomyocytes.
    Li RA; Miake J; Hoppe UC; Johns DC; Marbán E; Nuss HB
    J Physiol; 2001 May; 533(Pt 1):127-33. PubMed ID: 11351021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
    Sanguinetti MC; Curran ME; Zou A; Shen J; Spector PS; Atkinson DL; Keating MT
    Nature; 1996 Nov; 384(6604):80-3. PubMed ID: 8900283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome.
    Sesti F; Goldstein SA
    J Gen Physiol; 1998 Dec; 112(6):651-63. PubMed ID: 9834138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome.
    Shalaby FY; Levesque PC; Yang WP; Little WA; Conder ML; Jenkins-West T; Blanar MA
    Circulation; 1997 Sep; 96(6):1733-6. PubMed ID: 9323054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long QT syndrome: ionic basis and arrhythmia mechanism in long QT syndrome type 1.
    Sanguinetti MC
    J Cardiovasc Electrophysiol; 2000 Jun; 11(6):710-2. PubMed ID: 10868746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of I(Ks) suppression in LQT1 mutants.
    Bianchi L; Priori SG; Napolitano C; Surewicz KA; Dennis AT; Memmi M; Schwartz PJ; Brown AM
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3003-11. PubMed ID: 11087258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of mutations in KvLQT1 that cause long QT syndrome.
    Wang Z; Tristani-Firouzi M; Xu Q; Lin M; Keating MT; Sanguinetti MC
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):817-26. PubMed ID: 10376919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly.
    Schmitt N; Schwarz M; Peretz A; Abitbol I; Attali B; Pongs O
    EMBO J; 2000 Feb; 19(3):332-40. PubMed ID: 10654932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
    Kang J; Chen XL; Wang L; Rampe D
    J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional coupling of human beta 3-adrenoreceptors to the KvLQT1/MinK potassium channel.
    Kathöfer S; Zhang W; Karle C; Thomas D; Schoels W; Kiehn J
    J Biol Chem; 2000 Sep; 275(35):26743-7. PubMed ID: 10823835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease pathogenesis in long QT syndrome type 5.
    Harmer SC; Wilson AJ; Aldridge R; Tinker A
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C263-73. PubMed ID: 19907016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
    Yang IC; Scherz MW; Bahinski A; Bennett PB; Murray KT
    J Pharmacol Exp Ther; 2000 Sep; 294(3):955-62. PubMed ID: 10945846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location and orientation of minK within the I(Ks) potassium channel complex.
    Tapper AR; George AL
    J Biol Chem; 2001 Oct; 276(41):38249-54. PubMed ID: 11479291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New KCNQ1 mutations leading to haploinsufficiency in a general population; Defective trafficking of a KvLQT1 mutant.
    Gouas L; Bellocq C; Berthet M; Potet F; Demolombe S; Forhan A; Lescasse R; Simon F; Balkau B; Denjoy I; Hainque B; Baró I; Guicheney P;
    Cardiovasc Res; 2004 Jul; 63(1):60-8. PubMed ID: 15194462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation.
    Demolombe S; Lande G; Charpentier F; van Roon MA; van den Hoff MJ; Toumaniantz G; Baro I; Guihard G; Le Berre N; Corbier A; de Bakker J; Opthof T; Wilde A; Moorman AF; Escande D
    Cardiovasc Res; 2001 May; 50(2):314-27. PubMed ID: 11334835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-enriched LIM domain protein fhl2 is required to generate I(Ks) in a heterologous system.
    Kupershmidt S; Yang IC; Sutherland M; Wells KS; Yang T; Yang P; Balser JR; Roden DM
    Cardiovasc Res; 2002 Oct; 56(1):93-103. PubMed ID: 12237170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.